Personal tools

Coexpression cluster:C108

From FANTOM5_SSTAR

Revision as of 13:32, 12 September 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C108_breast_hepatoblastoma_MCF7_parotid_salivary_submaxillary_prostate



Phase1 CAGE Peaks

Hg19::chr10:37451700..37451715,+p@chr10:37451700..37451715
+
Hg19::chr10:37451725..37451728,+p@chr10:37451725..37451728
+
Hg19::chr10:37485037..37485044,+p@chr10:37485037..37485044
+
Hg19::chr10:37485774..37485794,+p@chr10:37485774..37485794
+
Hg19::chr10:37555522..37555528,+p@chr10:37555522..37555528
+
Hg19::chr10:37555579..37555584,+p@chr10:37555579..37555584
+
Hg19::chr10:37601250..37601252,+p@chr10:37601250..37601252
+
Hg19::chr10:37637623..37637627,+p1@VN1R53P
Hg19::chr10:37656774..37656778,+p@chr10:37656774..37656778
+
Hg19::chr10:37679189..37679193,+p@chr10:37679189..37679193
+
Hg19::chr10:37685495..37685497,+p@chr10:37685495..37685497
+
Hg19::chr10:9062678..9062682,-p@chr10:9062678..9062682
-
Hg19::chr10:9102477..9102481,-p@chr10:9102477..9102481
-
Hg19::chr10:9107734..9107754,-p@chr10:9107734..9107754
-
Hg19::chr11:113212368..113212375,+p9@TTC12
Hg19::chr11:120110546..120110551,-p@chr11:120110546..120110551
-
Hg19::chr11:67436996..67437009,-p@chr11:67436996..67437009
-
Hg19::chr11:67437863..67437876,-p@chr11:67437863..67437876
-
Hg19::chr11:72493645..72493661,-p23@STARD10
Hg19::chr11:72493668..72493679,-p22@STARD10
Hg19::chr11:7618413..7618427,+p6@PPFIBP2
Hg19::chr11:7618431..7618436,+p34@PPFIBP2
Hg19::chr11:7618437..7618448,+p20@PPFIBP2
Hg19::chr11:827914..827930,+p15@EFCAB4A
Hg19::chr11:827941..827978,+p10@EFCAB4A
Hg19::chr11:828104..828109,+p32@EFCAB4A
Hg19::chr11:828151..828163,+p14@EFCAB4A
Hg19::chr11:829412..829430,+p11@EFCAB4A
Hg19::chr11:829495..829500,+p23@EFCAB4A
Hg19::chr11:829538..829547,+p17@EFCAB4A
Hg19::chr11:829560..829573,+p13@EFCAB4A
Hg19::chr11:830434..830484,+p1@EFCAB4A
Hg19::chr11:831114..831132,+p@chr11:831114..831132
+
Hg19::chr12:49453217..49453224,+p@chr12:49453217..49453224
+
Hg19::chr12:90313394..90313420,+p1@ENST00000549551
Hg19::chr12:93806120..93806155,-p@chr12:93806120..93806155
-
Hg19::chr14:46389767..46389768,+p@chr14:46389767..46389768
+
Hg19::chr14:76447439..76447452,-p18@TGFB3
Hg19::chr14:76447469..76447487,-p12@TGFB3
Hg19::chr14:92302549..92302564,-p9@TC2N
Hg19::chr15:69854027..69854040,+p1@LOC145837
Hg19::chr15:69857515..69857518,+p3@ENST00000559477
Hg19::chr15:69857547..69857555,+p1@ENST00000559477
Hg19::chr15:69857557..69857562,+p2@ENST00000559477
Hg19::chr16:48281411..48281419,-p5@ABCC11
Hg19::chr16:48281444..48281451,-p2@ABCC11
Hg19::chr16:54972581..54972585,-p1@ENST00000558156
p1@ENST00000559802
Hg19::chr17:12935401..12935405,-p@chr17:12935401..12935405
-
Hg19::chr17:61514114..61514119,-p@chr17:61514114..61514119
-
Hg19::chr17:61514163..61514170,-p@chr17:61514163..61514170
-
Hg19::chr17:61514195..61514205,-p@chr17:61514195..61514205
-
Hg19::chr17:61514208..61514213,-p@chr17:61514208..61514213
-
Hg19::chr17:65990349..65990362,-p@chr17:65990349..65990362
-
Hg19::chr17:65990378..65990389,-p@chr17:65990378..65990389
-
Hg19::chr17:65990392..65990397,-p@chr17:65990392..65990397
-
Hg19::chr17:65990543..65990553,-p@chr17:65990543..65990553
-
Hg19::chr17:72968809..72968834,-p1@C17orf28
Hg19::chr17:72968837..72968868,-p2@C17orf28
Hg19::chr17:73389834..73389850,-p4@GRB2
Hg19::chr18:20911185..20911195,-p6@TMEM241
Hg19::chr19:15674405..15674438,+p@chr19:15674405..15674438
+
Hg19::chr19:15674459..15674486,+p@chr19:15674459..15674486
+
Hg19::chr19:48010224..48010231,-p@chr19:48010224..48010231
-
Hg19::chr19:5217451..5217456,-p@chr19:5217451..5217456
-
Hg19::chr1:11139818..11139830,-p6@EXOSC10
Hg19::chr1:153940716..153940739,+p4@CREB3L4
Hg19::chr1:153940741..153940751,+p7@CREB3L4
Hg19::chr1:164559541..164559546,+p52@PBX1
Hg19::chr1:164559556..164559568,+p21@PBX1
Hg19::chr1:164559583..164559590,+p50@PBX1
Hg19::chr1:189493099..189493102,-p@chr1:189493099..189493102
-
Hg19::chr1:190446662..190446678,-p6@FAM5C
Hg19::chr1:190446698..190446710,-p10@FAM5C
Hg19::chr1:190447673..190447683,-p@chr1:190447673..190447683
-
Hg19::chr1:233750790..233750823,-p@chr1:233750790..233750823
-
Hg19::chr1:236686445..236686452,+p18@LGALS8
Hg19::chr1:236686501..236686513,+p8@LGALS8
Hg19::chr1:31882617..31882630,+p4@SERINC2
Hg19::chr1:40598486..40598500,+p1@ENST00000430724
Hg19::chr1:47366146..47366153,-p1@CYP4Z2P
Hg19::chr1:51763556..51763631,-p2@TTC39A
Hg19::chr1:53559544..53559570,-p@chr1:53559544..53559570
-
Hg19::chr1:53559600..53559623,-p@chr1:53559600..53559623
-
Hg19::chr1:86889165..86889168,+p@chr1:86889165..86889168
+
Hg19::chr1:86889531..86889552,+p4@CLCA2
Hg19::chr1:86911063..86911068,+p@chr1:86911063..86911068
+
Hg19::chr1:94080063..94080068,-p23@BCAR3
Hg19::chr1:94080175..94080205,-p@chr1:94080175..94080205
-
Hg19::chr20:31781321..31781329,+p2@BPIFA4P
Hg19::chr20:34380919..34380924,+p@chr20:34380919..34380924
+
Hg19::chr20:60803269..60803302,+p@chr20:60803269..60803302
+
Hg19::chr20:62173412..62173437,-p@chr20:62173412..62173437
-
Hg19::chr21:36729875..36729891,+p@chr21:36729875..36729891
+
Hg19::chr21:37505138..37505151,-p@chr21:37505138..37505151
-
Hg19::chr21:43540870..43540878,+p10@UMODL1
Hg19::chr21:43540892..43540907,+p4@UMODL1
Hg19::chr21:43540912..43540915,+p15@UMODL1
Hg19::chr21:47704051..47704065,-p11@MCM3AP
Hg19::chr21:47704085..47704094,-p18@MCM3AP
Hg19::chr22:24990735..24990742,+p8@GGT2
p9@GGT1
Hg19::chr22:46283597..46283636,-p1@ENST00000451118
Hg19::chr2:142889034..142889073,-p4@LRP1B
Hg19::chr2:142889081..142889086,-p11@LRP1B
Hg19::chr2:142895398..142895426,-p1@ENST00000436132
Hg19::chr2:149863976..149863986,+p@chr2:149863976..149863986
+
Hg19::chr2:149864004..149864021,+p@chr2:149864004..149864021
+
Hg19::chr2:242674815..242674830,-p3@ENST00000400768
Hg19::chr2:242680762..242680768,+p@chr2:242680762..242680768
+
Hg19::chr2:242680772..242680783,+p@chr2:242680772..242680783
+
Hg19::chr2:242680789..242680804,+p@chr2:242680789..242680804
+
Hg19::chr2:242681835..242681844,+p5@D2HGDH
Hg19::chr3:141174789..141174790,-p8@AK129571
Hg19::chr3:14833061..14833093,+p@chr3:14833061..14833093
+
Hg19::chr3:149002564..149002570,+p1@ENST00000489011
Hg19::chr3:169587753..169587760,-p3@LRRC31
Hg19::chr3:169756594..169756605,+p9@GPR160
Hg19::chr3:169756638..169756645,+p15@GPR160
Hg19::chr3:169756667..169756675,+p14@GPR160
Hg19::chr3:169756689..169756695,+p13@GPR160
Hg19::chr3:189026705..189026726,+p@chr3:189026705..189026726
+
Hg19::chr3:189438863..189438865,+p@chr3:189438863..189438865
+
Hg19::chr3:4722258..4722271,+p@chr3:4722258..4722271
+
Hg19::chr3:4722283..4722286,+p@chr3:4722283..4722286
+
Hg19::chr3:4722301..4722324,+p@chr3:4722301..4722324
+
Hg19::chr3:60761167..60761179,+p@chr3:60761167..60761179
+
Hg19::chr3:60761181..60761194,+p@chr3:60761181..60761194
+
Hg19::chr3:9956047..9956079,+p@chr3:9956047..9956079
+
Hg19::chr4:14879181..14879226,-p@chr4:14879181..14879226
-
Hg19::chr4:160605526..160605546,-p@chr4:160605526..160605546
-
Hg19::chr4:160605585..160605628,-p@chr4:160605585..160605628
-
Hg19::chr4:776378..776392,+p@chr4:776378..776392
+
Hg19::chr5:111755562..111755580,-p@chr5:111755562..111755580
-
Hg19::chr5:111755583..111755641,-p@chr5:111755583..111755641
-
Hg19::chr5:148231224..148231235,+p@chr5:148231224..148231235
+
Hg19::chr5:148231243..148231244,+p@chr5:148231243..148231244
+
Hg19::chr5:153666993..153667004,+p9@GALNT10
Hg19::chr5:153667008..153667036,+p3@GALNT10
Hg19::chr5:176513895..176513924,+p1@FGFR4
Hg19::chr5:176513938..176513951,+p3@FGFR4
Hg19::chr5:176514238..176514245,+p18@FGFR4
Hg19::chr5:176518002..176518011,+p19@FGFR4
Hg19::chr5:176519127..176519154,+p@chr5:176519127..176519154
+
Hg19::chr5:180022690..180022710,-p@chr5:180022690..180022710
-
Hg19::chr6:10141294..10141304,+p@chr6:10141294..10141304
+
Hg19::chr6:34524093..34524135,-p1@SPDEF
Hg19::chr6:44013424..44013453,-p@chr6:44013424..44013453
-
Hg19::chr6:50785214..50785224,+p@chr6:50785214..50785224
+
Hg19::chr6:50785279..50785289,+p@chr6:50785279..50785289
+
Hg19::chr6:50786414..50786426,+p7@TFAP2B
Hg19::chr6:50786479..50786490,+p6@TFAP2B
Hg19::chr6:50786509..50786527,+p5@TFAP2B
Hg19::chr6:50786529..50786540,+p8@TFAP2B
Hg19::chr6:50789717..50789729,+p4@TFAP2B
Hg19::chr6:50789737..50789746,+p10@TFAP2B
Hg19::chr6:50836577..50836581,+p@chr6:50836577..50836581
+
Hg19::chr7:157285832..157285841,+p@chr7:157285832..157285841
+
Hg19::chr7:42429365..42429366,-p@chr7:42429365..42429366
-
Hg19::chr7:42429373..42429374,-p@chr7:42429373..42429374
-
Hg19::chr7:42429377..42429382,-p@chr7:42429377..42429382
-
Hg19::chr7:94277045..94277057,-p@chr7:94277045..94277057
-
Hg19::chr8:116684676..116684688,-p@chr8:116684676..116684688
-
Hg19::chr8:30584492..30584503,-p10@GSR
Hg19::chr8:30584507..30584514,-p13@GSR
Hg19::chr8:30584524..30584529,-p14@GSR
Hg19::chr8:30584533..30584543,-p9@GSR
Hg19::chr8:58943424..58943435,+p@chr8:58943424..58943435
+
Hg19::chr8:58943437..58943442,+p@chr8:58943437..58943442
+
Hg19::chr9:117379097..117379106,+p3@AB528759
Hg19::chr9:131870403..131870416,-p@chr9:131870403..131870416
-
Hg19::chr9:131871258..131871269,-p3@CRAT
Hg19::chr9:131871491..131871519,+p@chr9:131871491..131871519
+
Hg19::chr9:140506839..140506847,+p9@ARRDC1
Hg19::chr9:140506865..140506902,+p5@ARRDC1
Hg19::chrX:153603404..153603411,-p127@FLNA
Hg19::chrX:153603415..153603426,-p119@FLNA
Hg19::chrX:153603428..153603446,-p104@FLNA
Hg19::chrX:153603570..153603573,-p@chrX:153603570..153603573
-
Hg19::chrX:66763970..66763981,+p7@AR


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006606protein import into nucleus0.0214404100491165
GO:0051170nuclear import0.0214404100491165
GO:0006749glutathione metabolic process0.0214404100491165
GO:0017038protein import0.0229499729418118
GO:0006913nucleocytoplasmic transport0.0314709153876722
GO:0051169nuclear transport0.0314709153876722
GO:0001655urogenital system development0.0320263746614859
GO:0051990(R)-2-hydroxyglutarate dehydrogenase activity0.0320263746614859
GO:0004092carnitine O-acetyltransferase activity0.0320263746614859
GO:0032025response to cobalt ion0.0320263746614859
GO:0010042response to manganese ion0.0320263746614859
GO:0004362glutathione-disulfide reductase activity0.0320263746614859
GO:0048702embryonic neurocranium morphogenesis0.0320263746614859
GO:0006605protein targeting0.0355748464990184
GO:0043565sequence-specific DNA binding0.0367617866652938
GO:0018685alkane 1-monooxygenase activity0.0499155661978534
GO:0042221response to chemical stimulus0.0499155661978534
GO:0006732coenzyme metabolic process0.0499155661978534
GO:0007167enzyme linked receptor protein signaling pathway0.0499155661978534
GO:0030850prostate gland development0.0499155661978534
GO:0015038glutathione disulfide oxidoreductase activity0.0499155661978534
GO:0015037peptide disulfide oxidoreductase activity0.0499155661978534
GO:0016413O-acetyltransferase activity0.0499155661978534
GO:0045817positive regulation of global transcription from RNA polymerase II promoter0.0499155661978534
GO:0000176nuclear exosome (RNase complex)0.0499155661978534



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
epithelial cell3.46e-28254
endodermal cell3.93e-1059
endo-epithelial cell6.84e-0843
kidney cell5.90e-0718
kidney epithelial cell5.90e-0718
Uber Anatomy
Ontology termp-valuen
anatomical conduit1.04e-24241
multi-tissue structure4.11e-24347
anatomical cluster7.13e-24286
multi-cellular organism1.53e-23659
adult organism2.17e-22115
embryo5.44e-22612
cell layer8.59e-22312
epithelium1.04e-21309
organ part7.51e-20219
organism subdivision1.37e-19365
tube2.41e-19194
embryonic structure4.41e-19605
developing anatomical structure4.41e-19605
germ layer8.86e-19604
embryonic tissue8.86e-19604
presumptive structure8.86e-19604
epiblast (generic)8.86e-19604
anatomical system1.23e-18625
anatomical group1.24e-18626
endoderm-derived structure2.97e-17169
endoderm2.97e-17169
presumptive endoderm2.97e-17169
trunk region element1.28e-16107
subdivision of trunk4.37e-16113
subdivision of digestive tract6.04e-16129
endodermal part of digestive tract6.04e-16129
organ3.18e-15511
digestive system3.33e-15155
digestive tract3.33e-15155
primitive gut3.33e-15155
ectoderm3.63e-15173
presumptive ectoderm3.63e-15173
immaterial anatomical entity4.73e-15126
ectoderm-derived structure5.11e-15169
regional part of nervous system8.46e-1594
nervous system8.46e-1594
central nervous system1.93e-1482
neural plate3.04e-1486
presumptive neural plate3.04e-1486
neurectoderm3.12e-1490
neural tube5.66e-1457
neural rod5.66e-1457
future spinal cord5.66e-1457
neural keel5.66e-1457
head1.84e-13123
anterior region of body4.55e-13129
craniocervical region4.55e-13129
mixed endoderm/mesoderm-derived structure7.55e-13130
regional part of brain9.91e-1359
brain1.47e-1269
future brain1.47e-1269
anatomical space3.63e-12104
pre-chordal neural plate3.43e-1161
renal system1.23e-1045
abdomen element1.33e-1055
abdominal segment element1.33e-1055
anterior neural tube1.84e-1042
urinary system structure2.63e-1044
cavitated compound organ3.85e-1032
mesenchyme4.10e-10238
entire embryonic mesenchyme4.10e-10238
foregut4.40e-1098
regional part of forebrain6.23e-1041
forebrain6.23e-1041
future forebrain6.23e-1041
organ segment9.75e-1097
kidney3.47e-0927
kidney mesenchyme3.47e-0927
kidney rudiment3.47e-0927
kidney field3.47e-0927
abdominal segment of trunk3.55e-0961
abdomen3.55e-0961
gray matter4.35e-0934
brain grey matter4.35e-0934
endo-epithelium4.47e-0982
telencephalon9.70e-0934
trunk1.19e-08216
regional part of telencephalon1.55e-0833
cerebral hemisphere2.91e-0832
intermediate mesoderm6.21e-0837
mesonephros8.11e-0818
pronephros8.11e-0818
nephrogenic cord8.11e-0818
pronephric mesoderm8.11e-0818
rostral part of nephrogenic cord8.11e-0818
presumptive pronephric mesoderm8.11e-0818
respiratory system8.33e-0872
duct9.31e-0826
thoracic segment of trunk1.10e-0752
primordium1.25e-07168
thoracic segment organ2.30e-0735
excretory tube3.20e-0717
mesonephric epithelium3.20e-0717
mesonephric tubule3.20e-0717

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
EP300#2033451.712513357753060.0001652880030192290.00203351557866949
ESR1#2099132.247145184550610.005743764701949730.0258755571628748
FOXA1#3169493.050503189437578.75118373867725e-131.23675896953141e-10
GATA3#2625416.273579610367683.32876033620379e-218.89136574815314e-19



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data